SPDR S&P Pharmaceuticals ETF Rating $46.25 +0.09 (+0.19%) (As of 01:12 PM ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy2.72Holdings in XPH have an aggregate rating of Moderate Buy based on 353 analyst ratings issued in the past year covering 45 companies (100.0% of the portfolio).XPH Aggregate Price Target$67.1045.05% UpsideHigh Prediction$87.19Average Prediction$67.10Low Prediction$49.01Holdings in XPH have an aggregate price target of $67.10 and a range of $49.01 to $87.19 covering 45 companies (100.0% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy22 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 45 XPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.20%CORTCorcept Therapeutics$50.82+6.7%4.912 of 5 stars3.00$65.25 28.4%5Earnings ReportAnalyst Revision4.02%LBPHLongboard Pharmaceuticals$59.44-0.4%1.7159 of 5 stars2.44$59.56 0.2%9Upcoming Earnings3.67%BMYBristol-Myers Squibb$55.27+1.7%4.5239 of 5 stars1.93$53.00 -4.1%14Earnings ReportAnalyst ForecastAnalyst Revision3.64%EWTXEdgewise Therapeutics$33.98-0.1%1.9827 of 5 stars3.00$35.60 4.8%5Positive News3.58%JAZZJazz Pharmaceuticals$110.00-0.4%4.7899 of 5 stars2.79$173.43 57.7%14Upcoming Earnings3.54%ITCIIntra-Cellular Therapies$87.08+0.6%4.5925 of 5 stars2.85$96.62 11.0%13Earnings ReportAnalyst ForecastAnalyst Revision3.44%RPRXRoyalty Pharma$27.26+0.6%4.8126 of 5 stars2.83$41.67 52.8%6Upcoming Earnings3.42%CTLTCatalent$59.01+0.5%3.2381 of 5 stars2.00$59.83 1.4%83.41%VTRSViatris$11.48-1.2%2.5455 of 5 stars2.50$14.00 22.0%2Upcoming Earnings3.39%PFEPfizer$27.87-0.8%4.9865 of 5 stars2.60$33.58 20.5%15Earnings ReportAnalyst Revision3.39%ZTSZoetis$176.66-2.9%4.9851 of 5 stars3.10$221.44 25.4%10News CoverageGap Down3.38%AXSMAxsome Therapeutics$88.26-0.7%4.7771 of 5 stars3.00$124.64 41.2%14Positive News3.37%LLYEli Lilly and Company$808.38-1.3%4.8927 of 5 stars2.84$1,009.00 24.8%19Earnings ReportDividend AnnouncementAnalyst Revision3.37%JNJJohnson & Johnson$159.00-0.7%4.9787 of 5 stars2.54$175.93 10.6%133.22%MRKMerck & Co., Inc.$101.27-0.6%4.9993 of 5 stars2.88$129.93 28.3%17Earnings ReportAnalyst Forecast3.06%PRGOPerrigo$25.63-1.8%4.8722 of 5 stars2.75$37.00 44.4%4Upcoming EarningsDividend Announcement3.01%ELANElanco Animal Health$12.604.1639 of 5 stars2.43$17.00 34.9%7Upcoming Earnings2.93%OGNOrganon & Co.$16.89-6.5%4.8935 of 5 stars2.50$21.33 26.3%4Earnings ReportDividend Announcement2.86%SAVACassava Sciences$25.90-1.2%3.7141 of 5 stars3.00$111.50 330.5%2Upcoming Earnings2.70%ARVNArvinas$27.25+1.3%2.0404 of 5 stars2.87$56.92 108.9%15Earnings ReportAnalyst Revision2.20%AMPHAmphastar Pharmaceuticals$50.68-0.1%4.6389 of 5 stars2.50$63.00 24.3%4Upcoming EarningsAnalyst DowngradePositive News2.19%TARSTarsus Pharmaceuticals$47.51+0.4%1.3978 of 5 stars3.00$51.60 8.6%72.14%PBHPrestige Consumer Healthcare$74.24+0.3%4.4277 of 5 stars2.60$94.20 26.9%5Upcoming EarningsPositive News1.98%SUPNSupernus Pharmaceuticals$34.94+2.9%1.6193 of 5 stars2.50$36.00 3.0%21.95%PCRXPacira BioSciences$16.66+0.5%4.8055 of 5 stars2.20$24.20 45.3%10Upcoming Earnings1.88%COLLCollegium Pharmaceutical$33.58+0.4%4.1774 of 5 stars2.60$42.60 26.9%5Upcoming EarningsPositive News1.60%LGNDLigand Pharmaceuticals$110.17+0.1%4.8409 of 5 stars3.00$132.83 20.6%6Upcoming Earnings1.58%OCULOcular Therapeutix$10.46+0.7%4.1517 of 5 stars2.86$16.57 58.4%7Upcoming EarningsGap Down1.55%ANIPANI Pharmaceuticals$56.70-2.6%4.8488 of 5 stars2.83$77.33 36.4%6Upcoming Earnings1.52%HROWHarrow$46.38+1.6%3.339 of 5 stars3.00$56.67 22.2%3Positive News1.27%HRMYHarmony Biosciences$33.46+1.1%4.89 of 5 stars2.56$47.00 40.5%9Earnings Report1.23%AMRXAmneal Pharmaceuticals$8.48-0.1%2.9857 of 5 stars2.80$9.40 10.8%5Upcoming Earnings1.15%NMRANeumora Therapeutics$11.74+5.1%1.9845 of 5 stars2.86$22.83 94.5%71.12%WVEWave Life Sciences$14.00+1.2%4.9545 of 5 stars3.00$19.44 38.9%101.01%INVAInnoviva$19.39+0.7%1.5004 of 5 stars3.001Upcoming Earnings1.00%LQDALiquidia$10.66-2.9%3.72 of 5 stars2.90$24.67 131.4%10Upcoming Earnings0.99%EYPTEyePoint Pharmaceuticals$11.64-3.5%2.7626 of 5 stars3.00$29.00 149.1%9Upcoming Earnings0.97%PLRXPliant Therapeutics$15.07+3.8%4.0843 of 5 stars3.11$40.57 169.2%90.93%MNMDMind Medicine (MindMed)$6.09-0.8%1.5634 of 5 stars3.25$25.38 316.7%12Upcoming Earnings0.89%FULCFulcrum Therapeutics$3.34+4.0%3.5633 of 5 stars2.20$9.33 179.4%10Upcoming EarningsPositive News0.85%PHATPhathom Pharmaceuticals$18.63+2.0%1.5374 of 5 stars2.75$22.50 20.8%4Upcoming Earnings0.72%EOLSEvolus$16.49-1.6%4.0579 of 5 stars3.00$23.00 39.5%4Upcoming EarningsAnalyst Forecast0.71%ELVNEnliven Therapeutics$28.01+1.4%1.1969 of 5 stars3.25$34.33 22.6%40.50%NUVBNuvation Bio$2.35+2.2%3.5048 of 5 stars3.00$6.40 172.3%5Upcoming Earnings0.45%XERSXeris Biopharma$3.31+2.5%3.7882 of 5 stars3.00$4.67 41.0%3Upcoming Earnings This page (NYSEARCA:XPH) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
